ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2008 • 2019 ACR/ARP Annual Meeting

    Histone Lysine Methyltransferase MLL1 Regulates the Expression of Cytokines and Chemokines in Rheumatoid Arthritis Synovial Fibroblasts

    Yasuto Araki1, Keita Okamoto 1, Yoshimi Aizaki 1, Hiromi Oda 2 and Toshihide Mimura 1, 1Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan, 2Department of Orthopedic Surgery, Faculty of Medicine, Saitama Medical University, Saitama, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects the joints. The inflammatory process causes the activation of synovial fibroblasts (SFs) and…
  • Abstract Number: 2009 • 2019 ACR/ARP Annual Meeting

    Biomarkers Identified by Serum Inflammatory Profile Analysis to Predict Biologic Treatment Response in Rheumatoid Arthritis Patients

    Chary Lopez-Pedrera1, Nuria Barbarroja 2, Carlos Perez-Sanchez 3, Pilar Font 4, Alejandro Ibañez-Costa 1, Maria Luque-Tevar 1, Alejandra Patiño-Trives 1, Ivan Arias de la Rosa 4, Maria del Carmen Abalos-Aguilera 1, Rafaela Ortega 1, Alejandro Escudero 5, Laura Pérez-Sanchez 6, Jerusalem Calvo-Gutierrez 1, Rocío Segura-Ruiz 7, Carlos Rodriguez Escalera 8, Dolores Ruiz-Montesinos 9, Carmen Romero Barco 10, N. Mena-Vazquez 11, Julia Uceda Montañez 12, Mª Dolores Toledo Coello 13, M Angeles Aguirre 14 and Eduardo Collantes-Estevez 4, 1IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2University of Cordoba/IMIBIC/Reina Sofia Hospital and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain, 3Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, Cordoba, Spain, 4University of Cordoba/IMIBIC/Reina Sofia Hospital, Cordoba, Spain, 5IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, 6MIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, 7Reina Sofia University Hospital/IMIBIC, Córdoba, Spain, 8Hospital Universitario de Jaén, Jaen, Spain, 9Hospital Virgen Macarena, Sevilla, 10Hospital Marítimo de Torremolinos, Málaga, Málaga, Spain, 11HU Malaga., Malaga, 12Hospital Universitario Virgen de Valme, Sevilla, Sevilla, Spain, 13Hospital Universitario de Jerez de la Frontera, Cádiz, Cádiz, Spain, 14IMIBIC/Reina Sofia Hospital/University of Cordoba,, Córdoba, Spain

    Background/Purpose: Biologic disease modifying antirheumatic drugs (b-DMARDs) have revolutionized the management of Rheumatoid Arthritis (RA). Despite this success, a high percentage of the patients undergoing…
  • Abstract Number: 2010 • 2019 ACR/ARP Annual Meeting

    Individual Functions of Histone-acetyltransferases CBP and p300 in Regulating Autophagy and Proteasomal Degradation in Synovial Fibroblasts

    Monika Krošel1, Marcel Gabathuler 2, Matija Tomšič 1, Oliver Distler 3, Caroline Ospelt 4 and Kerstin Klein 5, 1Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, Ljubljana, Slovenia, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Switzerland, Schlieren, 3Dept. of Rheumatology, University Hospital Zürich, Zürich, Switzerland, Zürich, Switzerland, 4University Hospital Zürich, Zürich, Switzerland, 5Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Switzerland., Zürich, Switzerland

    Background/Purpose: Tight control of the two major catabolic pathways proteasomal degradation and autophagy is critical for the maintenance of cellular homeostasis and cell survival. Here…
  • Abstract Number: 2011 • 2019 ACR/ARP Annual Meeting

    Novel Somatic Mutations Identified by Whole Genome Sequencing of Rheumatoid Arthritis (RA) Fibroblast-Like Synoviocytes (FLS)

    Richard Ainsworth 1, Deepa Hammaker 2, David Boyle 1, Rizi Ai2, Jeremy Sokolove 3, Wei Wang 1 and Gary Firestein 2, 1University of California, San Diego, San Diego, CA, 2University of California, San Diego, San Diego, 3AbbVie Immunology Clinical Development, Redwood City

    Background/Purpose: Somatic mutations caused by reactive oxygen and nitrogen species in inflamed joints, have been implicated in the destructive nature of RA. Mutation analysis also…
  • Abstract Number: 2012 • 2019 ACR/ARP Annual Meeting

    A Composite IFN-Based Signature Is Associated with a Filgotinib-Specific Clinical Response in bDMARD-Experienced Rheumatoid Arthritis Patients

    Peter Taylor1, Bryan Downie 2, Emon Elboudwarej 3, Rachael Hawtin 3, Amer M. Mirza 3 and Jinfeng Liu 3, 1University of Oxford, Oxford, United Kingdom, 2Gilead Sciences, Inc., Foster Citty, CA, 3Gilead Sciences, Inc., Foster City, CA

    Background/Purpose: Filgotinib (FIL), an oral, selective, Janus Kinase 1 (JAK1) inhibitor was effective in Phase 3 studies of active RA in patients (pts) with inadequate…
  • Abstract Number: 2013 • 2019 ACR/ARP Annual Meeting

    Increased Accumulation of Malondialdehyde-Acetaldehyde Modified HDL in Macrophage Without Decreased Cholesterol Efflux

    Kevin Real1, Michael Duryee 1, Patrick Opperman 1, Evan Ryan 1, Logan Duryee 1, James O'Dell 2, Ted Mikuls 2, Daniel Anderson 1 and Geoffrey Thiele 2, 1University of Nebraska Medical Center, Omaha, NE, 2VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Patients with rheumatoid arthritis (RA) are approximately two-fold more likely to develop cardiovascular disease (CVD).  Prior reports have suggested that “dysfunctional” HDL may explain…
  • Abstract Number: 2014 • 2019 ACR/ARP Annual Meeting

    Loss-of-function of the DNA Repair Nuclease MRE11A Induces Mitochondrial Failure and Tissue Inflammation in Rheumatoid Arthritis

    Yinyin Li 1, Yi Shen 1, Ke Jin 1, Zhenke Wen 1, Wenqiang Cao 1, Bowen Wu 1, Ru Wen 1, Lu Tian 1, Gerald Berry 1, Jorg Goronzy 1 and Cornelia Weyand1, 1Stanford University, Stanford, CA

    Background/Purpose: Patients with rheumatoid arthritis (RA) accumulate tissue-invasive, pro-inflammatory CD4+ T cells. Such T cells are metabolically reprogrammed, favoring cytokine production, lipogenesis and membrane formation…
  • Abstract Number: 2015 • 2019 ACR/ARP Annual Meeting

    Methotrexate Treatment Is Associated with Reduction of Neutrophil Reactive Oxygen Species and CD177 in RA Patients

    Urvashi Kaundal 1, Varun Dhir1, Biman Saikia 1 and Aastha Khullar 1, 1Post Graduate Institute of Medical Education and Research, Chandigarh, India

    Background/Purpose: Methotrexate (MTX) is the gold-standard DMARD in rheumatoid arthritis, however, it is unclear how exactly it works. Its effects on neutrophils may involve reduction…
  • Abstract Number: 2016 • 2019 ACR/ARP Annual Meeting

    Expression of Peptidyl-arginine Deiminases in Peripheral Blood Neutrophils and Its Association with Single Nucleotide Variants in Patients with Rheumatoid Arthritis

    Masayoshi Harigai1, Ryoko Sakai 2, Takahiko Sugihara 3 and Akihito Ishigami 4, 1Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan, 2Department of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 3Tokyo Medical and Dental University, Tokyo, Japan, 4Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

    Background/Purpose: Peptidyl-arginine deiminases (PADIs) are enriched in neutrophils and considered to be responsible for citrullination of proteins in vivo. Autoantibody against citrullinated proteins are frequently…
  • Abstract Number: 2017 • 2019 ACR/ARP Annual Meeting

    Beyond Genes—a Multi-omic Analysis of Monozygotic Twins Discordant for Rheumatoid Arthritis

    Julia Manasson1, Jeremy Sokolove 2, Lauren Lahey 2, Adriana Heguy 1, Carles Ubeda 3 and Jose Scher 1, 1New York University School of Medicine, New York, NY, 2Stanford University School of Medicine, VA Palo Alto Medical Center, Stanford, CA, 3Centro Superior de Investigación en Salud Pública - FISABIO, Valencia, Spain

    Background/Purpose: Although a number of genetic factors, including susceptibility alleles, have been identified in rheumatoid arthritis (RA), the concordance rate in monozygotic (MZ) twins is…
  • Abstract Number: 2018 • 2019 ACR/ARP Annual Meeting

    Elevated Serum Levels of Tie-1 in Patients with Rheumatoid Arthritis

    Dylan Lee1, Chandra Mohan 2, Danielle Feger 3, Nancy Olsen 4 and Rayford June 4, 1Pennsylvania State M.S. Hershey Medical Center, Hershey, PA, 2Department of Biomedical Engineering, University of Houston,, Houston, 3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,, Baltimore, 4Pennsylvania State M.S. Hershey Medical Center, Hershey

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease that primarily affects patients’ peripheral joints and can lead to severe personal disability from progressive articular joint…
  • Abstract Number: 2019 • 2019 ACR/ARP Annual Meeting

    Tenosynovitis at the Metatarsophalangeal Joints, a Novel Feature of RA: Results from an Anatomical and Large Magnetic Resonance Imaging Study of Tendon Sheaths of the Forefoot

    Yousra Dakkak1, Friso Jansen 1, Marco DeRuiter 1, Monique Reijnierse 1 and Annette van der Helm-van Mil 2, 1Leiden University Medical Center, Leiden, Netherlands, 2LUMC, Leiden, Zuid-Holland, Netherlands

    Background/Purpose: Recent magnetic resonance imaging (MRI)-studies revealed that tenosynovitis in the hands is associated with rheumatoid arthritis (RA). Although the forefoot is a preferential location…
  • Abstract Number: 2020 • 2019 ACR/ARP Annual Meeting

    Metabolic Changes Induced by Anti-Malondialdehyde Antibodies Promote Osteoclast Development

    Koji Sakurabas1, Akilan Krishnamurthy 2, Cheng Xu 3, Khaled Amara 4, Vivianne Malmström 4, Sergiu-Bogdan Catrina 3, Caroline Grönwall 4, Bence Rethi 5 and Anca Catrina 6, 1Rheumatology unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Solna, stockholm, Sweden, 2Rheumatology unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Solna, Stockholm, 3Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden, 4Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Institutet, Stockholm, Sweden., Stockholm, Sweden, 5Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, 6Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden

    Background/Purpose: Malondialdehyde (MDA) is highly reactive compound produced by lipid-peroxidation in situations associated with oxidative stress. MDA can irreversibly modify proteins (e.g. lysine, arginine and histidine…
  • Abstract Number: 2021 • 2019 ACR/ARP Annual Meeting

    Higher Genetic Risk Load in Patients with More Diverse Manifestations in a Korean Systemic Lupus Erythematosus Cohort

    So-Young Bang1, Eunji Ha 2, Hyuk-Hee Kwon 3, Hyun-Seung Yoo 4, Juyeon Kang 1, Ji-Soong Kim 1, Bora Nam 1, Jung-Min Shin 1, Yeon-Kyung Lee 1, Tae-Han Lee 5, Hye-Soon Lee 6, Kwangwoo Kim 2 and Sang-Cheol Bae 1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 2Kyung Hee University, Seoul, Republic of Korea, 3Hanyang University Hospital, Guri, 4Hanyang University Hospital, Guri, Republic of Korea, 5Hanyang University, Seoul, 6Department of Internal Medicine, Hanyang University Guri Hospital,Hanyang University School of Medicine, Guri, Korea, Guri, Republic of Korea

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with diverse heterogeneous phenotypes. Although many studies of SLE presented estimates of high heritability, impact…
  • Abstract Number: 2022 • 2019 ACR/ARP Annual Meeting

    Analysis of Gene Expression from Systemic Lupus Erythematosus Synovium Reveals Unique Pathogenic Mechanisms

    Erika Hubbard1, Michelle Catalina 2, Sarah Heuer 1, Prathyusha Bachali 2, Nicholas Geraci 3, Peter Lipsky 3 and Amrie Grammer 1, 1AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA, 2AMPEL BioSolutions and the RILITE Research Institute, Charlottesville, VA, 3AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Arthritis is a common manifestation of SLE and the ability of a new lupus therapy often depends on its ability to suppress joint inflammation.…
  • « Previous Page
  • 1
  • …
  • 1072
  • 1073
  • 1074
  • 1075
  • 1076
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology